The roots and aerial parts of Chelidonium majus L. were extracted with EtOH and fractionated using CHCl 3 and EtOH. Repeated column chromatography, preparative TLC and crystallization led to the isolation of five isoquinoline alkaloids, stylopine (3), chelidonine (4), homochelidonine (5), protopine (6), and allocryptopine (7), along with two isolation artifacts 6-ethoxydihydrosanguinarine (1) and 6-ethoxydihydrochelerythrine (2). All isolated compounds were tested for human blood acetylcholinesterase (HuAChE) and human plasma butyrylcholinesterase (HuBuChE) inhibitory activity. The isolation artifacts exhibited the highest activity against HuAChE and HuBuChE with IC 50 values of 0.83 ± 0.04 μM and 4.20 ± 0.19 μM for 6-ethoxydihydrochelerythrine and 3.25 ± 0.24 μM and 4.51 ± 0.31 μM for 6-ethoxydihydrosanguinarine. The most active of the naturally-occurring alkaloids was chelidonine, which inhibited both HuAChE and HuBuChE in a dose-dependent manner with IC 50 values of 26.8 ± 1.2 μM and 31.9 ± 1.4 μM, respectively.
Alzheimer´s disease (AD) is the most predominant cause of dementia in the elderly. In AD patients, deficit of cholinergic functions, which results in decreased levels of the neurotransmitter acetylcholine (ACh) in the cortex, is responsible for the memory impairments [1] . The principal role of acetylcholinesterase (AChE) is the termination of nerve impulse transmission at the cholinergic synapses by rapid hydrolysis of acetylcholine (ACh). Inhibition of AChE serves as a strategy for the treatment of AD, senile dementia, ataxia, myasthenia gravis and Parkinson´s disease [2] . Moreover, in late AD stages, levels of AChE have declined by up to 85% and BuChE represents the predominant cholinesterase in the brain. BuChE, primarily associated with glial cells, but also with specific neuronal pathways, cleaves ACh in a manner similar to that of AChE to terminate its physiological action [3] . This fact has targeted BuChE as a new approach to intercede in the progression of AD and requires research of new inhibitors with dual enzymatic activity. Currently, cholinesterase inhibition is the most used therapeutic treatment for the symptoms of AD [4, 5] . In the screening of natural inhibitors of acetylcholinesterase, alkaloid extracts from species of Papaveraceae have demonstrated AChE inhibitory activity [6] . An overview of natural product inhibitors of AChE was reported by Hostettmann in 2006 [7] .
Chelidonium majus L. has been traditionally used as an herbal medicine for treatment of gastric ulcer, gastric cancer, oral infections and general pains in Asian and European countries. The orange latex of Ch. majus contains many isoquinoline alkaloids, at least twenty of which have been isolated and chemically identified. This complex group comprises a vast array of structural types, for example, protoberberines, aporphines, protopines, benzophenanthridines and pavines. Chelidonine, chelerythrine, sanquinarine, stylopine, protopine, allocryptopine and berberine are major alkaloids [8, 9] , with chelamidine, chelamine, chelidamine and chelilutine being present as minor components [10] . Among them, sanquinarine and chelerythrine have anti-inflammatory activity, chelidonine and protopine showed anti-tumor activity, and protoberberine exhibited anti-viral activity [8, 11, 12] .
In the course of screening for natural cholinesterase inhibitors, we found that the alkaloidal extract from Ch. majus showed promising cholinesterase activity. This communication deals with the isolation of five alkaloids and two isolation artifacts from this species, and reports the inhibitory effect of these compounds on the activity of erythrocyte AChE and plasma BuChE from human blood.
Column chromatography and preparative TLC led to the isolation of 7 compounds (1-7), five of which are alkaloids (3-7) that have already been reported for Ch. majus [10] . These were identified as: (-)-stylopine (3), (+)-chelidonine (4), (+)-homochelidonine (5), protopine (6) , and allocryptopine (7) [14] [15] [16] . In the presence of common solvents such as MeOH, EtOH and CHCl 3 , the free bases of benzophenanthridine alkaloids (sanquinarine and chelerythrine) easily produce adducts [17, 18] . In general, since these pseudobases do not occur in plants, compounds 1 and 2 must be considered as isolation artifacts; they were determined as 6-ethoxydihydrosanguinarine (1) and 6-ethoxydihydrochelerythrine (2) by comparison of their spectral data with those reported in the literature [17, 19, 20] . The inhibitory activity of isolated compounds 1-7 was studied in vitro using the colorimetric method of Ellman et al. [22] . Red blood cells were used as a source of AChE and human plasma of BuChE. The results are expressed as IC 50 values, with galanthamine and huperzine A as positive controls (Table 1) . Against BuChE huperzine A was inactive (IC 50 > 1 mM). Of the isolated compounds, the best AChE and BuChE inhibition was shown by the tertiary analogs of benzophenanthridine alkaloids sanguinarine and chelerythrine. It is known that compounds with quaternary nitrogen are active AChE inhibitors. The quaternary nitrogen plays an important role in binding with the enzyme [23] ; however, these compounds might have problems with crossing the blood-brain barrier [24] . Both isolated artifacts displayed higher activity against HuAChE and BuChE than the positive standard galanthamine; the IC 50 values of 6-ethoxydihydrosanguinarine (1) 
Acetylcholinesterase and butyrylcholinesterase assay:
HuAChE and HuBuChE activities were determined using a modified method of Ellman et al., [22] with acetylthiocholine and butyrylthiocholine as substrates, respectively. Briefly, 25-50 μL of either ghosts or plasma, 650 μL of DTNB and 25 μL of either the sample or appropriate solvent as a blank sample, were added to the semi-micro cuvette. The reaction was initiated by addition of substrate (ATChI or BuTChI). The final proportion of DTNB and substrate was 1:1. The increase of absorbance at 436 nm (∆A) was measured for 1 min using a spectrophotometer (Shimadzu UV-1611). Each measurement was repeated 3 times. The % inhibition was calculated according to the formula: %I = 100-(∆A BL /∆A SA )*100, where ∆A BL is the increase of absorbance of the blank sample and ∆A SA is the increase of absorbance of the measured sample.
